LAS VEGAS, July 9, 2014 /PRNewswire/
-- BioAdaptives, Inc. (OTC BB:
BDPT) announced that it is cleared by FINRA for quotation on
OTC Bulletin Board and OTC Link under the symbol BDPT effective as
of July 8, 2014. The company's
market maker is awaiting approval from The Depository Trust &
Clearing Corporation (DTCC) for DTC eligibility. A total of
2,000,419 shares are eligible for free trading, as noted within the
Form S-1 filing, and has been dispersed to shareholders of HEMP,
Inc. (Pink Sheets: HEMP) in a stock distribution.
Gerald Epling, President and
Chief Executive Officer of BioAdaptives, Inc., said, "We are on-track in becoming a
trading public company. News of our clearance and ticker
symbol was a big step in that direction. BioAdaptives™ is
working towards expanding its business. We are committed to
bringing high quality nutraceuticals to market for health and
wellness conscious consumers."
About BioAdaptives, Inc.
BioAdaptives, Inc. is a fully-reporting public company trading
on the OTC Bulletin Board under the symbol BDPT. The company is
engaged in research, development, and educational activities.
The company's focus is developing products to improve health and
wellness. These products include nutritional supplements and
proprietary methods of optimizing the bioelectromagnetic
availability of foods and beverages. For more information on
BioAdaptives, Inc. please visit www.bioadaptives.com.
SAFE HARBOR ACT
Forward-Looking Statements: This release contains statements
that constitute forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. These
statements appear in a number of places in this release and include
all statements that are not statements of historical fact regarding
the intent, belief or current expectations of BioAdaptives,
Inc. its directors or its officers
with respect to, among other things: (i) financing plans; (ii)
trends affecting its financial condition or results of operations;
(iii) growth strategy and operating strategy. The words "may,"
"would," "will," "expect," "estimate," "can," "believe,"
"potential" and similar expressions and variations thereof are
intended to identify forward-looking statements. Investors are
cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties, many of which are beyond BioAdaptives, Inc.'s ability to control, and actual
results may differ materially from those projected in the
forward-looking statements as a result of various factors. More
information about the potential factors that could affect the
business and financial results is and will be included in
BioAdaptives, Inc.'s filings with
the Securities and Exchange Commission.
SOURCE BioAdaptives, Inc.